Insider Selling: ASP Isotopes (NASDAQ:ASPI) CFO Sells 23,124 Shares of Stock

ASP Isotopes Inc. (NASDAQ:ASPI) CFO Heather Kiessling sold 23,124 shares of ASP Isotopes stock in a transaction that occurred on Wednesday, April 15th. The stock was sold at an average price of $5.48, for a total transaction of $126,719.52. Following the transaction, the chief financial officer owned 709,376 shares in the company, valued at approximately $3,887,380.48. The trade was a 3.16% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

ASP Isotopes Trading Up 5.1%

NASDAQ ASPI traded up $0.26 on Friday, hitting $5.37. 7,361,541 shares of the stock were exchanged, compared to its average volume of 4,528,583. ASP Isotopes Inc. has a 52-week low of $3.92 and a 52-week high of $14.49. The company has a debt-to-equity ratio of 1.04, a current ratio of 6.14 and a quick ratio of 6.10. The company has a market capitalization of $676.08 million, a price-to-earnings ratio of -2.51 and a beta of 3.59. The company’s 50-day moving average price is $5.06 and its two-hundred day moving average price is $6.73.

ASP Isotopes (NASDAQ:ASPI) last posted its quarterly earnings data on Friday, April 10th. The company reported ($0.84) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.70). ASP Isotopes had a negative return on equity of 307.82% and a negative net margin of 734.14%.The firm had revenue of $33.32 million for the quarter, compared to analysts’ expectations of $2.03 million. Research analysts predict that ASP Isotopes Inc. will post -0.24 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Alyeska Investment Group L.P. grew its stake in ASP Isotopes by 73.4% in the fourth quarter. Alyeska Investment Group L.P. now owns 4,895,546 shares of the company’s stock valued at $26,191,000 after purchasing an additional 2,072,851 shares in the last quarter. Vanguard Group Inc. grew its stake in ASP Isotopes by 37.9% in the third quarter. Vanguard Group Inc. now owns 4,516,763 shares of the company’s stock valued at $43,451,000 after purchasing an additional 1,241,024 shares in the last quarter. Rovida Investment Management Ltd grew its stake in ASP Isotopes by 28.1% in the fourth quarter. Rovida Investment Management Ltd now owns 4,100,000 shares of the company’s stock valued at $21,894,000 after purchasing an additional 900,000 shares in the last quarter. UBS Group AG grew its stake in ASP Isotopes by 150.3% in the fourth quarter. UBS Group AG now owns 2,406,457 shares of the company’s stock valued at $12,875,000 after purchasing an additional 1,445,165 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in ASP Isotopes by 28.0% in the fourth quarter. Geode Capital Management LLC now owns 2,384,066 shares of the company’s stock valued at $12,758,000 after purchasing an additional 521,611 shares in the last quarter. Hedge funds and other institutional investors own 16.80% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on ASPI. Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a research report on Friday, March 27th. Canaccord Genuity Group reiterated a “buy” rating and set a $11.00 price objective on shares of ASP Isotopes in a research report on Tuesday. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $13.00.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.